Emerging B cell lymphomas are characterized by high MYC levels and this model is widely used to study the mechanisms of MYC-driven lymphomagenesis (Boxer and Dang, 2001; Harris, 1988). Here, MYC is linked to B-cell non-Hodgkin lymphoma.